Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis

N Borisow, M Mori, S Kuwabara, M Scheel… - Frontiers in …, 2018 - frontiersin.org
Neuromyelitis optica spectrum disorders (NMOSD) are autoantibody mediated chronic
inflammatory diseases. Serum antibodies (Abs) against the aquaporin-4 water channel lead …

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD)–revised recommendations of the Neuromyelitis Optica Study Group …

T Kümpfel, K Giglhuber, O Aktas, I Ayzenberg… - Journal of …, 2024 - Springer
This manuscript presents practical recommendations for managing acute attacks and
implementing preventive immunotherapies for neuromyelitis optica spectrum disorders …

Neuromyelitis optica

S Jarius, F Paul, BG Weinshenker, M Levy… - Nature Reviews …, 2020 - nature.com
Neuromyelitis optica (NMO; also known as Devic syndrome) is a clinical syndrome
characterized by attacks of acute optic neuritis and transverse myelitis. In most patients …

Treatment of neuromyelitis optica spectrum disorder: acute, preventive, and symptomatic

RA Kessler, MA Mealy, M Levy - Current treatment options in neurology, 2016 - Springer
Opinion statement Neuromyelitis optica spectrum disorder (NMOSD) is a rare, autoimmune
disease of the central nervous system that primarily attacks the optic nerves and spinal cord …

Treatment of neuromyelitis optica spectrum disorders

KH Chan, CY Lee - International Journal of Molecular Sciences, 2021 - mdpi.com
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune central nervous system
(CNS) inflammatory disorder that can lead to serious disability and mortality. Females are …

Evaluation of efficacy and tolerability of first-line therapies in NMOSD

J Poupart, J Giovannelli, R Deschamps, B Audoin… - Neurology, 2020 - AAN Enterprises
Objective To compare the efficacy and the risk of severe infectious events of
immunosuppressive agents used early as first-line therapy in patients with neuromyelitis …

Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder

T Holmøy, RA Høglund, Z Illes, KM Myhr… - Journal of Neurology, 2020 - Springer
Background Treatment of neuromyelitis optica spectrum disorder (NMOSD) has so far been
based on retrospective case series. The results of six randomized clinical trials including five …

[HTML][HTML] Present and future therapies in neuromyelitis optica spectrum disorders

I Kleiter, R Gold - Neurotherapeutics, 2016 - Elsevier
Neuromyelitis optica spectrum disorders (NMOSD) are important evolving entities, which
have reached much attention in the recent years. NMOSD are characterized by inflammatory …

Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints

IH Jeong, B Park, SH Kim, JW Hyun… - Multiple Sclerosis …, 2016 - journals.sagepub.com
Background: There is still an unmet need for comparative analyses of available treatment
options for neuromyelitis optica spectrum disorder (NMOSD). Objective: We aimed to …

Progress in treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD

M Shi, F Chu, T Jin, J Zhu - CNS Neuroscience & Therapeutics, 2022 - Wiley Online Library
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune inflammatory
demyelinating disorder of the central nervous system (CNS), which is a severely disabling …